Amgen Sales Drive Profit Guidance Even as New Drugs Falter
Amgen Inc. raised its profit and revenue guidance for the year as the drugmaker’s overall second-quarter results exceeded Wall Street analysts’ expectations despite the underperformance of two key products. #press
